See more : Zhejiang CONBA Pharmaceutical Co.,Ltd. (600572.SS) Income Statement Analysis – Financial Results
Complete financial analysis of Jaguar Global Growth Corporation I (JGGCW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Jaguar Global Growth Corporation I, a leading company in the Shell Companies industry within the Financial Services sector.
- Transtema Group AB (TRANS.ST) Income Statement Analysis – Financial Results
- Redstone Resources Limited (RDS.AX) Income Statement Analysis – Financial Results
- Mida Assets Public Company Limited (MIDA.BK) Income Statement Analysis – Financial Results
- Metallus Inc. (MTUS) Income Statement Analysis – Financial Results
- Inpixon (INPX) Income Statement Analysis – Financial Results
Jaguar Global Growth Corporation I (JGGCW)
Industry: Shell Companies
Sector: Financial Services
Metric | 2022 | 2021 |
---|---|---|
Revenue | 0.00 | 0.00 |
Cost of Revenue | 0.00 | 0.00 |
Gross Profit | 0.00 | 0.00 |
Gross Profit Ratio | 0.00% | 0.00% |
Research & Development | 0.00 | 0.00 |
General & Administrative | 2.46M | 8.83 |
Selling & Marketing | 0.00 | 0.00 |
SG&A | 2.46M | 8.83 |
Other Expenses | 0.00 | -39.95K |
Operating Expenses | 2.46M | 53.27 |
Cost & Expenses | 2.46M | 53.27 |
Interest Income | 0.00 | 0.00 |
Interest Expense | 0.00 | 0.00 |
Depreciation & Amortization | -8.29M | 236.56K |
EBITDA | -10.75M | -44.44 |
EBITDA Ratio | 0.00% | 0.00% |
Operating Income | -2.46M | -8.83 |
Operating Income Ratio | 0.00% | 0.00% |
Total Other Income/Expenses | 8.07M | -44.44 |
Income Before Tax | 5.62M | -53.27 |
Income Before Tax Ratio | 0.00% | 0.00% |
Income Tax Expense | -8.07K | -44.44 |
Net Income | 5.62M | -53.27 |
Net Income Ratio | 0.00% | 0.00% |
EPS | 278.48 | -0.01 |
EPS Diluted | 0.18 | -0.01 |
Weighted Avg Shares Out | 30.67M | 6.67K |
Weighted Avg Shares Out (Dil) | 30.67M | 6.67K |
Source: https://incomestatements.info
Category: Stock Reports